Cyclopharm Ltd (CYC) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.362x

Based on the latest financial reports, Cyclopharm Ltd (CYC) has a cash flow conversion efficiency ratio of -0.362x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-9.83 Million ≈ $-6.95 Million USD) by net assets (AU$27.11 Million ≈ $19.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Cyclopharm Ltd (CYC) net asset quality to measure how much of total assets are equity-financed.

Cyclopharm Ltd - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Cyclopharm Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check CYC cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Cyclopharm Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cyclopharm Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Suominen Oyj HE:SUY1V	-0.099x
Asia Sejahtera Mina Tbk JK:AGAR	0.095x
Focus Lighting and Fixtures Limited NSE:FOCUS	0.153x
Bluebird bio Inc NASDAQ:BLUE	0.751x
Circus SE XETRA:CA1	N/A
Isbir Holding AS IS:ISBIR	0.484x
Batm Advanced Communications Ltd TA:BVC	-0.054x
Greatland Resources Limited LSE:GGP	0.460x

Annual Cash Flow Conversion Efficiency for Cyclopharm Ltd (2005–2025)

The table below shows the annual cash flow conversion efficiency of Cyclopharm Ltd from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Cyclopharm Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	AU$27.11 Million ≈ $19.18 Million	AU$-17.33 Million ≈ $-12.26 Million	-0.639x	-117.21%
2024-12-31	AU$42.73 Million ≈ $30.23 Million	AU$-12.57 Million ≈ $-8.90 Million	-0.294x	-31.89%
2023-12-31	AU$32.26 Million ≈ $22.83 Million	AU$-7.20 Million ≈ $-5.09 Million	-0.223x	-43.52%
2022-12-31	AU$36.54 Million ≈ $25.85 Million	AU$-5.68 Million ≈ $-4.02 Million	-0.155x	-310.91%
2021-12-31	AU$43.07 Million ≈ $30.47 Million	AU$-1.63 Million ≈ $-1.15 Million	-0.038x	+92.75%
2020-12-31	AU$17.12 Million ≈ $12.11 Million	AU$-8.93 Million ≈ $-6.32 Million	-0.522x	-2375.37%
2019-12-31	AU$23.20 Million ≈ $16.42 Million	AU$-489.34K ≈ $-346.24K	-0.021x	+67.59%
2018-12-31	AU$17.02 Million ≈ $12.04 Million	AU$-1.11 Million ≈ $-783.51K	-0.065x	-64.56%
2017-12-31	AU$17.25 Million ≈ $12.21 Million	AU$-682.12K ≈ $-482.64K	-0.040x	-175.26%
2016-12-31	AU$12.46 Million ≈ $8.82 Million	AU$654.79K ≈ $463.31K	0.053x	-83.43%
2015-12-31	AU$13.10 Million ≈ $9.27 Million	AU$4.15 Million ≈ $2.94 Million	0.317x	-44.96%
2014-12-31	AU$7.76 Million ≈ $5.49 Million	AU$4.47 Million ≈ $3.16 Million	0.576x	+198.54%
2013-12-31	AU$3.66 Million ≈ $2.59 Million	AU$706.71K ≈ $500.04K	0.193x	+715.72%
2012-12-31	AU$15.61 Million ≈ $11.04 Million	AU$369.29K ≈ $261.29K	0.024x	-38.69%
2011-12-31	AU$14.60 Million ≈ $10.33 Million	AU$563.63K ≈ $398.80K	0.039x	+684.06%
2010-12-31	AU$13.77 Million ≈ $9.74 Million	AU$-90.96K ≈ $-64.36K	-0.007x	-102.49%
2009-12-31	AU$13.93 Million ≈ $9.86 Million	AU$3.69 Million ≈ $2.61 Million	0.265x	+132.81%
2008-12-31	AU$13.06 Million ≈ $9.24 Million	AU$1.49 Million ≈ $1.05 Million	0.114x	+472.02%
2007-12-31	AU$7.34 Million ≈ $5.20 Million	AU$146.10K ≈ $103.37K	0.020x	+100.96%
2006-12-31	AU$-566.06K ≈ $-400.52K	AU$1.17 Million ≈ $827.14K	-2.065x	-1691.99%
2005-12-31	AU$11.34 Million ≈ $8.02 Million	AU$1.47 Million ≈ $1.04 Million	0.130x	--

About Cyclopharm Ltd

AU:CYC Australia Medical Distribution

Market Cap

$48.61 Million

AU$68.71 Million AUD

Market Cap Rank

#22006 Global

#780 in Australia

Share Price

AU$0.55

Change (1 day)

-2.68%

52-Week Range

AU$0.46 - AU$1.23

All Time High

AU$3.26